Daniel Kraft is a Stanford and Harvard-trained physician-scientist and innovator, and is the founder and chair of NextMed Health.
With over 25 years of experience in clinical practice, biomedical research, and healthcare innovation, he has focused on the cross-disciplinary advancement of health and medicine. Daniel is the founder and chair of NextMed Health (founded in 2011 and previously called Exponential Medicine), a platform and community that explores the convergence of rapidly developing technologies and their potential to reshape healthcare and biomedicine. He has served as faculty chair for Medicine at Singularity University since its inception in 2008. Kraft is the chair of the XPRIZE Pandemic & Health Alliance.
Following undergraduate degrees from Brown University and medical school at Stanford, Daniel became board-certified in Internal Medicine and pediatrics after completing a Harvard residency at Massachusetts General Hospital and Boston Children’s Hospital and fellowships in hematology, oncology, and bone marrow transplantation at Stanford.
He has multiple scientific publications (including in Nature and Science) and medical device, immunology, and stem cell-related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.
Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and is a member of the Kaufman Fellows Society. He is often called upon to discuss the future of health, medicine, and technology. He has given four TED talks and two TEDMED Talks and delivered keynote addresses to a diverse array of leading organizations.
Daniel’s academic research has focused on stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. His clinical work has focused on bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children and medical devices to enable stem cell-based regenerative medicine, including marrow-derived stem cell harvesting, processing, and delivery.
He is heavily involved in digital health, having founded Digital Health and advising several Fortune 50 and digital health-related startups. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow. He founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies.
Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He conducted research on aerospace medicine that was published by NASA, with whom he was a finalist for astronaut selection.
- Bachelor of Arts in Biochemistry, Brown University
- Medical Doctor, Stanford University School of Medicine
- Residency: Harvard Combined Residency in Internal Medicine & Pediatrics
- Fellowships: Stanford Hematology/Oncology & Bone Marrow Transplantation
- Aspen Institute Health Innovators Fellow: Member of Inaugural class.
